← All indications
Impetigo
A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.
Drugs by status
Approved for this indication (3)
Phase 4 trials (4)
Phase 3 trials (2)
Phase 2 trials (3)
Phase 1 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (9)
- Union Therapeutics
- Foamix Ltd.
- Lytix Biopharma AS
- Novum Pharmaceutical Research Services
- Institute of Dermatology and Skin Surgery, Dr. Hubert Bogaert Diaz, Santo Domingo
- Dr. Robert Reid Cabral Children hospital, Santo Domingo
- Hospital Infantil Dr. Robert Reid Cabral
- J&S Studies Inc.
- Anniston Medical Clinic
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (3)